PURPOSE: We evaluated the validity and interrater reliability of encephalographer interpretation of color density spectral array EEG for seizure identification was evaluated in critically ill children and explored predictors of accurate seizure identification. METHODS: Conventional EEG tracings from 21 consecutive critically ill children were scored for electrographic seizures. Four 2-hour long segments from each subject were converted to 8-channel color density spectral array displays, yielding 84 images. Eight encephalographers received color density spectral array training and circled elements thought to represent seizures. Images were reviewed in random order (Group A) or with information regarding seizure presence in the initial 30 minutes and with subject images in order (Group B). Sensitivity, specificity, and interrater reliability were calculated. Factors associated with color density spectral array seizure identification were assessed. RESULTS: Seizure prevalence was 43% on conventional EEG. Specificity was significantly higher for Group A than Group B (92.3% vs. 78.2%, P < 0.00). Sensitivity was not significantly different between Groups A and B (64.8% vs. 75%, P = 0.22). Interrater reliability was moderate in both groups. Ten percent of images were falsely classified as containing a seizure. Seizure duration ≥2 minutes predicted identification (P < 0.001). CONCLUSIONS: Color density spectral array may be a useful screening tool for seizure identification by encephalographers, but it does not identify all seizures and false positives occur.
PURPOSE: We evaluated the validity and interrater reliability of encephalographer interpretation of color density spectral array EEG for seizure identification was evaluated in critically ill children and explored predictors of accurate seizure identification. METHODS: Conventional EEG tracings from 21 consecutive critically ill children were scored for electrographic seizures. Four 2-hour long segments from each subject were converted to 8-channel color density spectral array displays, yielding 84 images. Eight encephalographers received color density spectral array training and circled elements thought to represent seizures. Images were reviewed in random order (Group A) or with information regarding seizure presence in the initial 30 minutes and with subject images in order (Group B). Sensitivity, specificity, and interrater reliability were calculated. Factors associated with color density spectral array seizure identification were assessed. RESULTS:Seizure prevalence was 43% on conventional EEG. Specificity was significantly higher for Group A than Group B (92.3% vs. 78.2%, P < 0.00). Sensitivity was not significantly different between Groups A and B (64.8% vs. 75%, P = 0.22). Interrater reliability was moderate in both groups. Ten percent of images were falsely classified as containing a seizure. Seizure duration ≥2 minutes predicted identification (P < 0.001). CONCLUSIONS: Color density spectral array may be a useful screening tool for seizure identification by encephalographers, but it does not identify all seizures and false positives occur.
Authors: Nicholas S Abend; Ana Gutierrez-Colina; Huaqing Zhao; Rong Guo; Eric Marsh; Robert R Clancy; Dennis J Dlugos Journal: J Clin Neurophysiol Date: 2011-02 Impact factor: 2.177
Authors: Hansel M Greiner; Katherine Holland; James L Leach; Paul S Horn; Andrew D Hershey; Douglas F Rose Journal: Pediatrics Date: 2012-02-13 Impact factor: 7.124
Authors: N S Abend; A M Gutierrez-Colina; A A Topjian; H Zhao; R Guo; M Donnelly; R R Clancy; D J Dlugos Journal: Neurology Date: 2011-02-09 Impact factor: 9.910
Authors: Fenella J Kirkham; Angela M Wade; Fiona McElduff; Stewart G Boyd; Robert C Tasker; Melinda Edwards; Brian G R Neville; Norbert Peshu; Charles R J C Newton Journal: Intensive Care Med Date: 2012-04-11 Impact factor: 17.440
Authors: Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch Journal: J Clin Neurophysiol Date: 2015-04 Impact factor: 2.177
Authors: Edilberto Amorim; Craig A Williamson; Lidia M V R Moura; Mouhsin M Shafi; Nicolas Gaspard; Eric S Rosenthal; Mary M Guanci; Venkatakrishna Rajajee; M Brandon Westover Journal: J Clin Neurophysiol Date: 2017-07 Impact factor: 2.177
Authors: Alexis A Topjian; Michael Fry; Abbas F Jawad; Susan T Herman; Vinay M Nadkarni; Rebecca Ichord; Robert A Berg; Dennis J Dlugos; Nicholas S Abend Journal: Pediatr Crit Care Med Date: 2015-06 Impact factor: 3.624
Authors: Geneviève Du Pont-Thibodeau; Sarah M Sanchez; Abbas F Jawad; Vinay M Nadkarni; Robert A Berg; Nicholas S Abend; Alexis A Topjian Journal: Pediatr Crit Care Med Date: 2017-04 Impact factor: 3.624
Authors: Ayham Alkhachroum; Saptharishi Lalgudi Ganesan; Johannes P Koren; Julie Kromm; Nina Massad; Renz A Reyes; Michael R Miller; David Roh; Sachin Agarwal; Soojin Park; Jan Claassen Journal: Neurocrit Care Date: 2021-11-17 Impact factor: 3.210
Authors: J J Halford; D Shiau; J A Desrochers; B J Kolls; B C Dean; C G Waters; N J Azar; K F Haas; E Kutluay; G U Martz; S R Sinha; R T Kern; K M Kelly; J C Sackellares; S M LaRoche Journal: Clin Neurophysiol Date: 2014-11-20 Impact factor: 3.708
Authors: Hiba A Haider; Rosana Esteller; Cecil D Hahn; M Brandon Westover; Jonathan J Halford; Jong W Lee; Mouhsin M Shafi; Nicolas Gaspard; Susan T Herman; Elizabeth E Gerard; Lawrence J Hirsch; Joshua A Ehrenberg; Suzette M LaRoche Journal: Neurology Date: 2016-07-27 Impact factor: 9.910